GlassScriptPhysician profile
Paula M Hernandez
NPI 1316559289
$2,636.03
in general payments reported to CMS, 2019-2025
17 companies · $904 in 2025
The $904 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $125 · 2023: $572 · 2024: $1,036 · 2025: $904.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,511.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $857.16 | 2023-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $382.55 | 2023-2025 | |
| Novo Nordisk INC | $288.83 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $160.61 | 2023-2025 | Mounjaro, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $152.32 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $140.33 | 2022-2023 | |
| Abbott Laboratories | $90.27 | 2024-2025 | Aveir, Assurity, Freestyle Libre 3 |
| Pfizer INC. | $89.53 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $87.24 | 2024-2025 | Rexulti |
| Glaxosmithkline, LLC. | $70.50 | 2023-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Boston Scientific Corporation | $66.58 | 2023-2024 | Watchman Flx |
| Lundbeck LLC | $60.34 | 2024-2025 | Rexulti |
| Edwards Lifesciences Corporation | $59.53 | 2025 | Sapien 3 Ultra Resilia |
| Shield Therapeutics INC | $42.44 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.10 | 2023 | Jardiance |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $31.50 | 2024 | Otezla, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.20 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paula Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.